Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 149   

Articles published

BMY 49.80 0.00 (0.00%)
price chart
Bristol-Myers Squibb Popular Amongst Latest 13F Filers
At Holdings Channel, we have reviewed the latest batch of the 30 most recent 13-F filings for the 06/30/2014 reporting period, and noticed that Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY) was held by 14 of these funds.
This month in 1989: the creation of Bristol-Myers Squibb
It was also in this particular period on July 28, 1989, that two US companies agreed to form what would become at the time the world's second biggest pharma company - Bristol-Myers Squibb (BMS). The stock-swap merger between Bristol-Myers and Squibb ...
Bristol-Myers Squibb's �Neutral� Rating Reaffirmed at Zacks (BMY)  Mideast Time
Bristol-Myers Squibb PT Raised to $34.00 at MKM Partners (BMY)  Watch List News (press release)
Related articles »  
Monday's Hot Stocks: Bristol-Myers Squibb Company (NYSE:BMY), VirnetX ...
Bristol-Myers Squibb Company (NYSE:BMY) second quarter 2014 earnings (excluding special items and the diabetes business divested earlier in the year) of 46 cents per share beat the Zacks Consensus Estimate by 2 cents.
Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce Strategic ...
NEW YORK, NY, USA & OSAKA, Japan I July 23, 2014 I Bristol-Myers Squibb Company(NYSE:BMY) andOno Pharmaceutical Co., Ltd.
Bristol-Myers profits beat estimates as it readies new immuno-harnessing ...  Fortune
Related articles »  
Bristol-Myers Squibb Rating Reiterated by Zacks (BMY)
Bristol-Myers Squibb Co logo Bristol-Myers Squibb (NYSE:BMY)'s stock had its �neutral� rating restated by Zacks in a report issued on Friday.
Market Activity and Upcoming Quarterly Results - Analyst Notes on Bristol ...
Bristol-Myers Squibb Co Analyst Notes On July 1, 2014, Bristol-Myers Squibb Co (Bristol-Myers Squibb) reported that it will release its Q2 2014 financial results on July 24, 2014.
Related articles »  
Bristol-Myers Squibb Announces Plans for Third Quarter Submission of a ...
PRINCETON, N.J., Jul 10, 2014 (BUSINESS WIRE) -- Bristol-Myers Squibb Company (NYSE:BMS) today announced that, following discussions with the U.S.
Bristol-Myers Squibb To File Biologics Licensing Application For Opdivo In Q3  NASDAQ
Bristol-Myers Squibb Selects GEP To Provide Strategic Category Management ...  Businessweek
Related articles »  
Worth Watching Stocks - Arena Pharmaceuticals, Inc. (ARNA), Bristol-Myers ...
BioMed Realty Trust, Inc. (BMR) recently informed that Bristol-Myers Squibb Co (NYSE:BMY), has signed a ten-year lease for approximately 61,000 square feet of additional laboratory and office space at the company's Woodside Technology Park life science ...
Bristol-Myers Squibb Becomes #189 Most Shorted S&P 500 Component ...  Forbes
Momentum Stocks: Bristol-Myers Squibb (NYSE:BMY), Coca-Cola Enterprises ...  eMarketsDaily
Related articles »  
Bristol-Myers Squibb Company - Product Pipeline Review - 2014
This report provides comprehensive information on the current therapeutic developmental pipeline of Bristol-Myers Squibb Company's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), ...
Analyst Downgrades: SunPower Corporation, Bristol-Myers Squibb Co, and ...  Schaeffers Research (blog)
Bristol-Myers recalls six lots of blood thinner injection  Fox Business
Related articles »  
Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase ...
PRINCETON, N.J. & NEW YORK, Jul 17, 2014 (BUSINESS WIRE) -- Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced that the first patient has been enrolled into a Phase IV clinical trial called EMANATE (Eliquis ...
Bristol-Myers Squibb Co (NYSE:BMY), Pfizer Inc. (NYSE:PFE) Enroll Patients ...
Related articles »